Bcl-2 antisense oligodeoxynucleotide increases the sensitivity of leukemic cells to arsenic trioxide

Cell Biology International

Volumn 27, Issue 12, 2003, Pages 953-958

  Zhang, Y ^a   Shen, W L ^a  

^a MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

Author keywords

Antisense oligonucleotide; Apoptosis; Arsenic trioxide; bcl 2; Leukemia

Indexed keywords

ANTINEOPLASTIC AGENT; ANTISENSE OLIGONUCLEOTIDE; ARSENIC TRIOXIDE; BCL 2 ANTISENSE PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDE; PROTEIN BCL 2; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CELL CULTURE; CONTROLLED STUDY; DRUG SENSITIVITY; FLOW CYTOMETRY; GROWTH INHIBITION; HISTOCHEMISTRY; HUMAN; HUMAN CELL; LEUKEMIA CELL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE;

EID: 0344011096     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1065-6995(03)00164-1     Document Type: Article

References (11)

1. Bai Y.H., Huan S.L. Studies on red orpiment induction of NB4 and HL-60 cell apotosis. Chin J Hematol. 19:(9):1998;477-480.
2. 3exerts dose-dependent sual effects on APL cells. Blood. 89:(9):1997;3345-3353.
3. Chen G.Q., Zhu J., Shi X.G., et al. In vitro studies on cellular and molecular mechanisms of arsenic trioxide in the treatment of acute promyelocytic leukemia: arsenic induces NB4 cell apoptosis with down regulation of BCL-2 and modulation of PML-RAR protein. Blood. 88:1996;1052.
4. Fong P.S. Analytic chemistry of arsenic. 1986;45-60 Chinese Environment Science Publishing House.
5. He Z.G., Zhang Y. Effect of antisense oligodeoxynucleotide of bcl-2on drug sensitivity of leukemic cells. Chin J Pathophysiol. 14:(6):1998;591-595. (in Chinese).
6. Hu X.M., Ma L., Hu N.P., Wang Z.F., Liang L., Li L., et al. Ailing No. 1 in treating 62 cases of acute promyelocytic leukemia. Chinese Journal of Integrated Traditional and western medicine. 19:(8):1999;473-476. (in Chinese).
7. Keith F.J., Bradburg D.A., Zhu Y.M., et al. Inhibition of bcl-2 with antisense oligonucleotide induces apoptosis and increase the sensitivity of AML blasts to Ara-C. Leukemia. 76:(2):1995;112-115.
8. 3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapse patients. Blood. 89:(9):1997;3354-3360.
9. Xiao D.M., Sen G.L., Wu W.L., Su H., Li J., Dai Q.Y., et al. Protein tyrosine kinase activities during the induction of apoptosis by arsenic trioxide. Chin J Hematol. 19:(5):1998;234-236.
10. Ziegler A., Luedke G.H., Fabbro D. Induction of apoptosis in small cell lung cancer cells by an antisende oligodeoxynucleotide targeting the bcl-2 coding sequence. J Natl Cancer Inst. 89:(14):1997;1027-1036.
11. Zhang Y., Nie L. Studies of apoptosis of malignant lymphoma cells induced by arsenic trioxide. Cell Biol Int. 25:(10):2001;1003-1006.